Parame, Erlinda .

HRN: 24-05-37  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/12/2023
AMPICILLIN 1GM (VIAL)
11/12/2023
11/18/2023
IV
2g
Q6
PROM
Checking Final Appropriateness 
11/13/2023
CO-AMOXICLAV 625MG (TAB)
11/13/2023
11/20/2023
PO
625 Mg
BID
TMSAF
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: